🇺🇸 FDA
Patent

US 10683366

Methods and compositions for treatment of atherosclerosis

granted A61KA61K2039/505A61K31/713

Quick answer

US patent 10683366 (Methods and compositions for treatment of atherosclerosis) held by The Board of Regents of the University of Texas System expires Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 16 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 11 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K2039/505, A61K31/713, A61K38/00, A61K45/06